Patient and Provider Perspectives on Genetic Risk Profiling
About this study
A qualitative interview study exploring the patient and provider perspectives on the clinical utility of genetic risk profiling in routine clinical practice. The findings from the study may contribute towards future research and informing clinical practice.
- Condition
- Prostate Cancer
- Tested
- Qualitative interview
- Sponsor
- Royal Marsden NHS Foundation Trust
Who can join
- Age
- 18 to 100 years
- Sex
- Male only
- Healthy volunteers
- Accepted
Inclusion 8
- Minimum age: 18 years
- Maximum age: 100 years
- Eligible sex: Male
- Study condition: Prostate Cancer
- Individuals assigned male at birth who are aged 18 and over and who have capacity to consent
- Patients who have undergone genetic risk profiling for prostate cancer and have received their results
- Individuals from diverse backgrounds (age, ethnicity, risk status, etc)
- Healthcare providers who have delivered a genetic risk profiling result for prostate cancer
Exclusion 2
- Individuals who lack capacity to consent
- Individuals deemed unsuitable to recruit based on their poor performance status or current medical condition
Where
1 site, 1 recruiting
The Royal Marsden Hospital (Sutton and Chelsea)
London, United Kingdom
Contact
-
Tarryn Shaw, MSc
020 8661 3375 tarryn.shaw@rmh.nhs.uk
-
Elizabeth Bancroft, RN PhD
02087224483 elizabeth.bancroft@rmh.nhs.uk
Potential match only. Final eligibility is determined by the study team.